Home

Opiat Förstena störta cara kappa opioid segmentet Klibbig hållning

SEC Filing | Cara Therapeutics
SEC Filing | Cara Therapeutics

Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for  Multiple Pathologies
Frontiers | The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New  Directions for the Treatment of Pain, Anxiety, Depression,
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression,

Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug  Development | SpringerLink
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) |  Seeking Alpha
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha

Peripheral kappa opioid receptor activation drives cold hypersensitivity in  mice | bioRxiv
Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice | bioRxiv

Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for  the Development of Potential Treatments of Pain with Reduced Side Effects
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

Novel Compound Promising Alternative to Current Opioids
Novel Compound Promising Alternative to Current Opioids

PDF) The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple  Pathologies
PDF) The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

Kappa opioid receptor binding affinity and the effects on... | Download  Scientific Diagram
Kappa opioid receptor binding affinity and the effects on... | Download Scientific Diagram

Will peripherally restricted kappa‐opioid receptor agonists (pKORAs)  relieve pain with less opioid adverse effects and abuse potential? -  Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics -  Wiley Online Library
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library

Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds  that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal  Pain | Journal of Medicinal Chemistry
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain | Journal of Medicinal Chemistry

Strategies for Developing κ Opioid Receptor Agonists for the Treatment of  Pain with Fewer Side Effects | Journal of Pharmacology and Experimental  Therapeutics
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics

Cara Therapeutics Announces Topline Results From KARE Phase 2 Dose-Ranging  Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with  Moderate-to-Severe Pruritus | National Eczema Association
Cara Therapeutics Announces Topline Results From KARE Phase 2 Dose-Ranging Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus | National Eczema Association

Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds  that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal  Pain | Journal of Medicinal Chemistry
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain | Journal of Medicinal Chemistry

Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class  of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink

A systematic review on the kappa opioid receptor and its ligands: New  directions for the treatment of pain, anxiety, depression, and drug abuse -  ScienceDirect
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect

Strategies for Developing κ Opioid Receptor Agonists for the Treatment of  Pain with Fewer Side Effects | Journal of Pharmacology and Experimental  Therapeutics
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics

PDF) Targeting Peripheral Kappa Opioid Receptors for the Treatment of  Chronic Pain: Review Article
PDF) Targeting Peripheral Kappa Opioid Receptors for the Treatment of Chronic Pain: Review Article

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and  central itch circuits - Kim - 2022 - Experimental Dermatology - Wiley  Online Library
Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits - Kim - 2022 - Experimental Dermatology - Wiley Online Library

Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a  peripherally restricted, selective kappa opioid receptor agonist that  exerts antipruritic effects by means of activation of kappa opioid  receptors on peripheral neurons
Nephrology Journal Club on X: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons